PubRank

Efficacy Study of Herbal Formula CUF2 to Treat Childhood Asthma

Clinical Trial ID NCT00636103

PubWeight™ 0.83‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00636103

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987 6.69
2 Prevalence of asthma and allergy in Hong Kong schoolchildren: an ISAAC study. Eur Respir J 1997 1.24
3 Treatment of acute bronchiolitis with Chinese herbs. Arch Dis Child 1993 0.99
4 Liquid chromatography-electrospray ionization mass spectrometry study of the flavonoids of the roots of Astragalus mongholicus and A. membranaceus. J Chromatogr A 2000 0.95
5 Evaluation of efficacy of traditional Chinese medicines in the treatment of childhood bronchial asthma: clinical trial, immunological tests and animal study. Taiwan Asthma Study Group. Pediatr Allergy Immunol 1996 0.89
6 Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: a comparison of fluticasone with beclomethasone. Eur Respir J 1999 0.85
7 Chinese herbal medicine in the treatment of asthma and allergies. Clin Rev Allergy Immunol 1996 0.85
8 Randomized, double-blind, placebo-controlled trial of herbal therapy for children with asthma. J Altern Complement Med 2009 0.83
9 Prevalence and risk factors of childhood asthma, rhinitis and eczema in Hong Kong. J Paediatr Child Health 1998 0.82
10 Alternative therapies and medical science: designing clinical trials of alternative/complementary medicines--is evidence-based traditional Chinese medicine attainable? J Clin Pharmacol 2000 0.79
11 Anti-inflammatory triterpenoids from mysterious mushroom Ganoderma lucidum and their potential possibility in modern medicine. Acta Medica (Hradec Kralove) 1999 0.77
12 Characterization of an alkali-extracted peptidoglycan from Korean Ganoderma lucidum. Arch Pharm Res 1999 0.75
Next 100